Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBSX
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBoston Scientific Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 19, 1992
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ1979
āļāļĩāļāļĩāđāļMr. Michael F. (Mike) Mahoney
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ53000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 19
āļāļĩāđāļāļĒāļđāđ300 Boston Scientific Way
āđāļĄāļ·āļāļMARLBOROUGH
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ01752-1234
āđāļāļĢāļĻāļąāļāļāđ15086834000
āđāļ§āđāļāđāļāļāđhttps://www.bostonscientific.com/en-US/Home.html
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBSX
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 19, 1992
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ1979
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. John E. Sununu
Independent Director
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Ms. Ellen M. Zane
Independent Director
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. David C. Habiger
Independent Director
Mr. Yoshiaki Fujimori
Independent Director
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
Ms. Meghan Scanlon
Senior Vice President and President - Urology
Senior Vice President and President - Urology
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. John E. Sununu
Independent Director
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Ms. Ellen M. Zane
Independent Director
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
Mr. David C. Habiger
Independent Director
iShares U.S. Medical Devices ETF
Goldman Sachs Future Health Care Equity ETF
Invesco Dorsey Wright Healthcare Momentum ETF
JPMorgan Healthcare Leaders ETF
iShares Health Innovation Active ETF
Health Care Select Sector SPDR Fund
Proshares Ultra Health Care
Knowledge Leaders Developed World ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ11.22%
Goldman Sachs Future Health Care Equity ETF
āļŠāļąāļāļŠāđāļ§āļ8.79%
Invesco Dorsey Wright Healthcare Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ5.45%
NYLI Healthy Hearts ETF
āļŠāļąāļāļŠāđāļ§āļ5.03%
JPMorgan Healthcare Leaders ETF
āļŠāļąāļāļŠāđāļ§āļ4.31%
Tema Heart & Health ETF
āļŠāļąāļāļŠāđāļ§āļ3.68%
iShares Health Innovation Active ETF
āļŠāļąāļāļŠāđāļ§āļ3.61%
Health Care Select Sector SPDR Fund
āļŠāļąāļāļŠāđāļ§āļ3.25%
Proshares Ultra Health Care
āļŠāļąāļāļŠāđāļ§āļ3.25%
Knowledge Leaders Developed World ETF
āļŠāļąāļāļŠāđāļ§āļ3.23%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ